Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Schwerte
Clinical trial register · Germany

Clinical Trials in Schwerte, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2869
Recruiting now
open to new participants
983
Lead sponsors
across recruiting studies
Top sites
Berlin 1587 Hamburg 893 Essen 765 Dresden 714 Heidelberg 626
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
European Organisation for Research and Treatment of Cancer - EORTC1
Site location
Berlin1587 Hamburg893 Essen765 Dresden714 Heidelberg626 Cologne619 Leipzig513 München510 Hanover487 Tübingen454 Bonn422 Düsseldorf409 Munich398 Freiburg im Breisgau394 Erlangen374 Frankfurt369 Münster359 Frankfurt am Main343 Ulm343 Mainz336 Würzburg296 Aachen266 Augsburg248 Kiel234 Lübeck225 Show all 638
All 638 locations
Target enrolment
to

Trials with a site in Schwerte

1 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
366
Essen, Frankfurt am Main, Homburg / Saar, Offenburg, Ravensburg, Schwerte, Stuttgart, Torgau
2019-06-14
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-germany/city/schwerte

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 10 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Schwerte.

How many clinical trials are recruiting in Schwerte?

0 of the 1 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Schwerte), 1 studies
PhaseStudiesRecruitingShare
Phase 210100%

Most active sponsors

Lead sponsors with the most studies (Schwerte)
Lead sponsorStudiesRecruiting
European Organisation for Research and Treatment of Cancer - EORTC10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.